Clinical Trials
3 trialsNCT06038526 2026-05-20
Evaluation of Canakinumab in High-Risk Former-Smokers
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT04931017 2025-10-07
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
Northwestern University
Phase 2 Active not recruiting
NCT05411107 2024-05-17
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
National Cancer Institute (NCI)
Phase 2 Withdrawn